当前位置:
X-MOL 学术
›
Curr. Opin. Gastroenterol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Diagnosis and management of immune mediated liver injury from checkpoint inhibitors.
Current Opinion in Gastroenterology ( IF 2.5 ) Pub Date : 2024-02-16 , DOI: 10.1097/mog.0000000000001015 Alisa Likhitsup , Robert J. Fontana
Current Opinion in Gastroenterology ( IF 2.5 ) Pub Date : 2024-02-16 , DOI: 10.1097/mog.0000000000001015 Alisa Likhitsup , Robert J. Fontana
The aim is to summarize the latest data on the incidence, clinical manifestations, and management of immune- mediated liver injury from checkpoint inhibitors (ILICI).
中文翻译:
检查点抑制剂免疫介导的肝损伤的诊断和治疗。
目的是总结检查点抑制剂(ILICI)引起的免疫介导的肝损伤的发病率、临床表现和治疗的最新数据。
更新日期:2024-02-16
中文翻译:
检查点抑制剂免疫介导的肝损伤的诊断和治疗。
目的是总结检查点抑制剂(ILICI)引起的免疫介导的肝损伤的发病率、临床表现和治疗的最新数据。